SCHEMBL4907422

SCHEMBL4907422

CCN(Sc1ccc(Oc2ccc(C)cc2)cc1)S(=O)(=O)c1cc(C)c(C)c(C(=O)O)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCL1 Q07820 5/20 0.41
CYP2C9 P11712 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C19 P33261 1/20 0.39
PTGES O14684 1/20 0.37
ALOX5 P09917 1/20 0.37
GFER P55789 1/20 0.35
HTT P42858 3/20 0.35
LMNA P02545 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
BCL2L1 Q07817 3/20 0.35
POLB P06746 2/20 0.35
APEX1 P27695 1/20 0.35
CTDSP1 Q9GZU7 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
MMP9 P14780 2/20 0.35
MMP1 P03956 1/20 0.35
MMP13 P45452 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4905862 0.94 POLB (0.41) MCL1PTGESHTTLMNASMN1; SMN2
SCHEMBL4904426 0.92 TDP1 (0.36) MCL1CYP2C9CYP1A2CYP2C19HTT
SCHEMBL4906155 0.92 MCL1 (0.35) MCL1PTGESALOX5HTTLMNA
SCHEMBL4908223 0.92 TAS2R14 (0.36) MCL1HTTLMNASMN1; SMN2NPC1
SCHEMBL4902983 0.91 ALDH1A1 (0.39) MCL1CYP2C9CYP1A2CYP2C19HTT
SCHEMBL4902692 0.90 MCL1 (0.39) MCL1BCL2L1POLBAPEX1CTDSP1
SCHEMBL4895687 0.89 L3MBTL1 (0.39) MCL1CYP2C9CYP1A2CYP2C19PTGES
SCHEMBL4902549 0.89 LMNA (0.38) MCL1CYP2C9CYP1A2CYP2C19HTT
SCHEMBL4902749 0.89 PPARD (0.37)
SCHEMBL4902550 0.89 TRPM8 (0.38) MMP9MMP1NR3C1ALDH1A1MMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD MCL1 4319/4885CYP2C9 3557/4885CYP1A2 2009/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD MCL1 4319/4885CYP2C9 3557/4885CYP1A2 2009/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.